This Week's Top Healthcare News Could Cause These Stocks Pop or Drop

<p><span style="font-family: Calibri, Arial, Helvetica, sans-serif; font-size: 16px;">Novartis nabs approval for a drug that could revolutionize how we treat heart disease and CVS Health doubles down on its anti-tobacco stance. Our Motley Fool's Michael Douglass and Todd Campbell discuss what it means for the companies involved.</span></p>